NEW YORK (GenomeWeb) – Next-generation sequencing-based clinical diagnostics firm Blueprint Genetics today announced it has raised $3.9 million to fund its international expansion.

It is unclear if the $3.9 million figure is the amount the Finnish firm raised in the most recent financing round or if it is the total amount raised since its founding. On deadlinie, the company did not respond to a request for clarification.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.